Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kruithof

Showing results (41-50 of 493) with videos related to

Pageof 50
Sort By:
Health & Social Care in the Community|March 2, 2022
Gaining 'clarity through specificity' in invited patient participation: A case study of a multifaceted participatory practice in the NetherlandsKasper Kruithof, Clementine Wijkmans, Lotte Ruijter, et al.
Thrombosis and Haemostasis|April 30, 1986
Studies on the release of a plasminogen activator inhibitor by human plateletsE K Kruithof, C Tran-Thang, F Bachmann
Research in Developmental Disabilities|December 26, 2021
Parents' views on medical decisions related to life and death for their ageing child with profound intellectual and multiple disabilities: A qualitative studyKasper Kruithof, Erik Olsman, Appolonia Nieuwenhuijse, et al.
Health Promotion International|June 24, 2022
Participatory research in health promotion: a critical review and illustration of rationalesJanneke Harting, Kasper Kruithof, Lotte Ruijter, et al.
Journal of Biomolecular NMR|September 23, 2010
Analysis of (1)H chemical shifts in DNA: Assessment of the reliability of (1)H chemical shift calculations for use in structure refinementS S Wijmenga, M Kruithof, C W Hilbers
Thrombosis and Haemostasis|February 28, 1986
The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinaseE K Kruithof, C Tran-Thang, F Bachmann
The Journal of Clinical Investigation|December 1, 1984
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clotsC Tran-Thang, E K Kruithof, F Bachmann
The Journal of Cell Biology|March 1, 1987
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cellsC Genton, E K Kruithof, W D Schleuning
Journal of Intellectual & Developmental Disability|January 17, 2025
"I hope I'll outlive him": A qualitative study of parents' concerns about being outlived by their child with profound intellectual and multiple disabilitiesKasper Kruithof, Erik Olsman, Appolonia Nieuwenhuijse, et al.
The International Journal of Developmental Biology|March 14, 2014
Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2Boudewijn P T Kruithof, Marianna Kruithof-De-Julio, Robert E Poelmann, et al.
Pageof 50

Showing results (41-50 of 493) with videos related to

Sort By:
Pageof 50
Health & Social Care in the Community|March 2, 2022
Gaining 'clarity through specificity' in invited patient participation: A case study of a multifaceted participatory practice in the NetherlandsKasper Kruithof, Clementine Wijkmans, Lotte Ruijter, et al.
Thrombosis and Haemostasis|April 30, 1986
Studies on the release of a plasminogen activator inhibitor by human plateletsE K Kruithof, C Tran-Thang, F Bachmann
Research in Developmental Disabilities|December 26, 2021
Parents' views on medical decisions related to life and death for their ageing child with profound intellectual and multiple disabilities: A qualitative studyKasper Kruithof, Erik Olsman, Appolonia Nieuwenhuijse, et al.
Health Promotion International|June 24, 2022
Participatory research in health promotion: a critical review and illustration of rationalesJanneke Harting, Kasper Kruithof, Lotte Ruijter, et al.
Journal of Biomolecular NMR|September 23, 2010
Analysis of (1)H chemical shifts in DNA: Assessment of the reliability of (1)H chemical shift calculations for use in structure refinementS S Wijmenga, M Kruithof, C W Hilbers
Thrombosis and Haemostasis|February 28, 1986
The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinaseE K Kruithof, C Tran-Thang, F Bachmann
The Journal of Clinical Investigation|December 1, 1984
Tissue-type plasminogen activator increases the binding of glu-plasminogen to clotsC Tran-Thang, E K Kruithof, F Bachmann
The Journal of Cell Biology|March 1, 1987
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cellsC Genton, E K Kruithof, W D Schleuning
Journal of Intellectual & Developmental Disability|January 17, 2025
"I hope I'll outlive him": A qualitative study of parents' concerns about being outlived by their child with profound intellectual and multiple disabilitiesKasper Kruithof, Erik Olsman, Appolonia Nieuwenhuijse, et al.
The International Journal of Developmental Biology|March 14, 2014
Remodeling of the myocardium in early trabeculation and cardiac valve formation; a role for TGFβ2Boudewijn P T Kruithof, Marianna Kruithof-De-Julio, Robert E Poelmann, et al.
Pageof 50